hims & hers health, FDA and Trump

Why Hims & Hers Stock Jumped on Massive FDA News
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Hims & Hers jumps after Trump nominates Dr. Marty Makary for FDA
Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns
Johns Hopkins Marty Makary, Trump’s choice for FDA, a ‘brilliant surgeon’ with some ‘worrisome’ views
Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,
Who is Dr. Marty Makary, Trump’s pick to head the FDA?
The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against “natural fat.”
Trump’s FDA nom has harsh language for chemicals in food
If confirmed as FDA commissioner, Dr. Marty Makary would oversee testing on foods for pollutants like "forever chemicals" and heavy metals.
Money Morning1d
Three Stocks: Nano Nuclear Energy, Cassava Sciences, and Hims & Hers
Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology ...
Hims & Hers New Growth Category Is a Huge Surprise
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead
Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...
bovnews2d
Hims & Hers Health Inc (HIMS) Stock: More Strategic Than Meets the Eye
On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $25.33 which represents a slight increase of $1.18 or 4.89% from the prior close of $24.15. The stock opened at ...
AOL14d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy
Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...
Wall Street Journal12d
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...
Forbes4d
What’s Happening With HIMS Stock?
The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of ...
Hims & Hers surges: Analysts say it's well-positioned under Trump
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...